Published in Curr Opin Microbiol on August 01, 2002
A phenotypic profile of the Candida albicans regulatory network. PLoS Genet (2009) 2.86
A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med (2005) 2.35
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell (2007) 2.25
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother (2003) 1.49
A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc Natl Acad Sci U S A (2008) 1.48
Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp. J Nat Prod (2009) 1.46
Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell (2010) 1.46
Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother (2009) 1.31
Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet (2013) 1.20
Systems-level antimicrobial drug and drug synergy discovery. Nat Chem Biol (2013) 1.19
Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation. Eukaryot Cell (2007) 1.16
Drug resistance is not directly affected by mating type locus zygosity in Candida albicans. Antimicrob Agents Chemother (2003) 1.15
Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob Agents Chemother (2005) 1.06
Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Chemother (2008) 1.06
A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis (2008) 1.04
Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Chemother (2006) 1.02
Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus. J Nat Prod (2006) 1.01
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One (2009) 0.98
Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance. Antimicrob Agents Chemother (2006) 0.98
Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. PLoS Genet (2013) 0.97
Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering. Genome Biol (2010) 0.97
Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother (2005) 0.96
Proteomic analysis of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother (2004) 0.95
Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother (2006) 0.94
Genetic Basis of Antifungal Drug Resistance. Curr Fungal Infect Rep (2009) 0.90
Will resistance in fungi emerge on a scale similar to that seen in bacteria? Eur J Clin Microbiol Infect Dis (2008) 0.88
Drug Strategies Targeting CYP51 in Neglected Tropical Diseases. Chem Rev (2014) 0.86
Cytochrome P450 monooxygenase CYP53 family in fungi: comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug target. PLoS One (2014) 0.85
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei. Eur J Clin Microbiol Infect Dis (2004) 0.84
Chemogenomic and transcriptome analysis identifies mode of action of the chemosensitizing agent CTBT (7-chlorotetrazolo[5,1-c]benzo[1,2,4]triazine). BMC Genomics (2010) 0.81
Gene expression and evolution of antifungal drug resistance. Antimicrob Agents Chemother (2009) 0.81
Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates. Front Microbiol (2016) 0.79
Synthesis, structure optimization and antifungal screening of novel tetrazole ring bearing acyl-hydrazones. Int J Mol Sci (2012) 0.79
Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans. PLoS One (2011) 0.78
Exploring the molecular basis of antifungal synergies using genome-wide approaches. Front Microbiol (2012) 0.78
New subfamilies of major intrinsic proteins in fungi suggest novel transport properties in fungal channels: implications for the host-fungal interactions. BMC Evol Biol (2014) 0.77
Molecular Characterization of Gβ-Like Protein CpcB Involved in Antifungal Drug Susceptibility and Virulence in A. fumigatus. Front Microbiol (2016) 0.76
Molecular Insights into the Fungus-Specific Serine/Threonine Protein Phosphatase Z1 in Candida albicans. MBio (2016) 0.75
High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines. PLoS Genet (2016) 0.75
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Front Microbiol (2017) 0.75
Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species. BMC Microbiol (2016) 0.75
Microwave assisted synthesis, spectral and antifungal studies of 2-phenyl-N,N'-bis(pyridin-4-ylcarbonyl)butanediamide ligand and its metal complexes. ScientificWorldJournal (2014) 0.75
Role of bacterial biofilm in development of middle ear effusion. Eur Arch Otorhinolaryngol (2016) 0.75